Influence of analytical bias and imprecision on the number of false positive results using Guideline-Driven Medical Decision Limits

Clinica Chimica Acta

Volumn 430, Issue , 2014, Pages 1-8

  Hyltoft Petersen, Per ^a   Klee, George G ^b  

^a UNIVERSITY OF BERGEN   (Norway)

^b MAYO CLINIC   (United States)

Author keywords

Analytical bias; Analytical imprecision; Analytical quality specifications; Clinical guidelines; Clinical outcome; Probability function

Indexed keywords

CALCIUM; CHOLESTEROL; HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ANALYTIC METHOD; ANALYTICAL ERROR; ANALYTICAL PARAMETERS; ARTICLE; CALCIUM BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; GUIDELINE DRIVEN MEDICAL DECISION LIMITS; HUMAN; IMPRECISION; ISCHEMIC HEART DISEASE; LABORATORY TEST; MALE; MEDICAL DECISION MAKING; PERFORMANCE; PRIORITY JOURNAL; QUALITY CONTROL; RISK FACTOR; BLOOD; CORONARY DISEASE; DECISION SUPPORT SYSTEM; DIAGNOSTIC PROCEDURE; LABORATORY DIAGNOSIS; PRACTICE GUIDELINE; STANDARDS; STATISTICAL BIAS;

BIAS (EPIDEMIOLOGY); CALCIUM; CHOLESTEROL; CLINICAL LABORATORY TECHNIQUES; CORONARY DISEASE; DECISION MAKING, COMPUTER-ASSISTED; DIABETES MELLITUS; FALSE POSITIVE REACTIONS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; PRACTICE GUIDELINES AS TOPIC;

EID: 84891654051     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2013.12.014     Document Type: Article

References (33)

1. Strategies to set global analytical quality specifications in laboratory medicine. Scan J Clin Lab Invest 1999, 59:475-585. P. Hyltoft Petersen, C.G. Fraser, A. Kallner, D. Kenny (Eds.).
2. Kenny D., Fraser C.G., Hyltoft Petersen P., Kallner A. Scand J Clin Lab Invest 1999, 59:585.
3. Hyltoft Petersen P., Fraser C.G. Strategies to set global analytical quality specifications in laboratory medicine: 10years on from the Stockholm consensus conference. Accred Qual Assur 2010, 15:323-330.
4. Klee G.G. Establishment of outcome-related analytical performance goals. Clin Chem 2010, 56:714-722.
5. Gallaher PM, Mobley RL, Klee GG, Schryver P, preparers. The impact of calibration error in medical decision making. Final report. [Gaithersburg, MD]: National Institute of Standards and Technology, Chemical Science and Technology Laboratory; 2004. Report nr: Planning report04-1. Available at: http://www.nist.gov/director/prog-ofc/report04%971.pdf.
6. BIPM, IEC, IFCC, et al. International vocabulary of metrology-basic and general concepts and associated terms (VIM). JCGM 200 2012, [http://www.bipm.org/]. 3rd ed.
7. Hyltoft Petersen P., Stöckl D., Westgard J.O., Sandberg S., Linnet K., Thienpont L. Models for combining random and systematic errors. Assumptions and consequences for different models. Clin Chem Lab Med 2001, 39:589-595.
8. Harris E.K. Proposed goals for analytical precision and accuracy in single-point diagnostic testing. Arch Pathol Lab Med 1988, 112:416-420.
9. BIPM, IEC, IFCC, et al. Evaluation of measurement data-guide to the expression of uncertainty in measurement GUM. JCGM 100 2008, [http://www.bipm.org/]. 2nd ed.
10. Westgard J.O., Barry P.L. Cost-effective quality control: managing the quality and productivity of analytical processes 1986, AACC Press, 1725 K Street, NW Washington, DC 20006.
11. Oosterhuis W.P. Gross overestimation of total allowable error based on biological variation. Clin Chem 2011, 57:1334-1336.
12. Gowans E.M.S., Hyltoft Petersen P., Blaabjerg O., Hørder M. Analytical goals for the acceptance of common reference intervals for laboratories throughout a geographical area. Scand J Clin Lab Invest 1988, 48:757-764.
13. Hyltoft Petersen P., Fraser C.G., Jørgensen L., et al. Combination of analytical quality specifications based on biological within- and between-subject variation. Ann Clin Biochem 2002, 39:543-550.
14. White G.H. Basics of estimating measurement uncertainty. Clin Biochem Rev August 2008, 29(Suppl. (i)):S53.
15. Sacks D.B., Arnold M., Bakris G.L., et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care 2011, 34:c61-c99.
16. Garber A.M., Browner W.S. American College of Physicians guidelines for using serum cholesterol, high-density lipoprotein cholesterol, and triglyceride levels as screening tests for preventing coronary heart disease in adults. Ann Intern Med 1996, 124:515-517.
17. Hyltoft Petersen P., Jensen E.A., Brandslund I. Analytical performance, reference values and decision limits. A need to differentiate between reference intervals and decision limits and to define analytical quality specifications. Clin Chem Lab Med 2012, 50:819-831.
18. Harris E.K. Statistical principles underlying analytical goal-setting in clinical chemistry. Am J Clin Pathol 1979, 72:374-382.
19. PetitClerc C., Solberg H.E. Approved recommendation (1987) on the theory of reference values. Part 2. Selection of individuals for the production of reference values. J Clin Chem Clin Biochem 1987, 25:639-644.
20. Jørgensen L.G.M., Stahl M., Brandslund I., Hyltoft Petersen P., Borch-Johnsen K., de Fine Olivarius N. Plasma glucose reference interval in a low-risk population 2. Impact of the new WHO and ADA recommendations on diagnosis of diabetes mellitus. Scand J Clin Lab Invest 2001, 61:181-190.
21. Hyltoft Petersen P., Brandslund I., Jørgensen L.G.M., Stahl M., de Fine Olivarius N., Borch-Johnsen K. Evaluation of systematic and random factors in measurements of fasting plasma glucose as the basis for analytical quality specifications in the diagnosis of diabetes. 3. Impact of the new WHO and ADA recommendations on diagnosis of diabetes mellitus. Scand J Clin Lab Invest 2001, 61:191-204.
22. Hyltoft Petersen P., Jørgensen L.G.M., Brandslund I., de Fine Olivarius N., Stahl M. Consequences of bias and imprecision in measurements of glucose and HbA1c for the diagnosis and prognosis of diabetes mellitus. Scand J Clin Lab Invest 2005, 65(Suppl. 240):51-60.
23. Weykamp C., John G., Mosca A. A review of the challenges in measuring haemoglobin A1c. J Diabetes Sci Technol 2009, 3:439-445.
24. Nordin G. Coefficient of variation for hemoglobin A1c results that are traceable to national glycohemoglobin standardization program must be distinguished from coefficient of variation for results traceable to international federation of clinical chemistry and laboratory medicine. Diabetes Tecnol Ther 2011, 13:1271-1272.
25. Jørgensen L.G.M., Brandslund I., Stahl M., et al. Upper reference limit, analytical quality specifications and clinical use of haemoglobin A1C. Scand J Clin Lab Invest 2002, 62:609-622.
26. 1c in healthy persons and in type 1 diabetes patients. Clin Chem Lab Med 2011, 49:1501-1507.
27. Fokkema M.R., Herrmann Z., Muskiet F.A., Moecks J. Reference change values for brain natriuretic peptides revisited. Clin Chem 2006, 52(8):1602-1603.
28. Jørgensen L.G.M., Hyltoft Petersen P., Brandslund I. The impact of variability in the risk of disease exemplified by diagnosing diabetes mellitus based on ADA and WHO criteria as gold standard. Int J Risk Assess Manag 2005, 5:358-373.
29. Ricós C., Alvarez V., Cava F., et al. Current databases on biological variation: pros, cons and progress. Scand J Clin Lab Invest 1999, 59:491-500.
30. Bland J.M., Altman D.G. Comparing methods of measurements: why plotting difference against standard method is misleading. Lancet 1995, 346:1085-1087.
31. Garde A.H., Hansen Å.M., Skovgaard L.T., Christensen J.M. Seasonal and biological variation of blood concentrations of total cholesterol, dehydroepiandrosterone sulphate, Haemoglobin A1c, IgA, prolactin and free testosterone in healthy women. Clin Chem 2000, 46:551-559.
32. Vickers A.J., Lilja H. Cutpoints in clinical chemistry: time for fundamental reassessment. Clin Chem 2009, 55:15-17.
33. Sørensen P.D., Jakobsen E.H., Madsen J.S., et al. Serum HER-2: sensitivity, specificity, and predictive values for detecting metastatic recurrence in breast cancer patients. J Cancer Res Clin Oncol 2013, 139:1005-1013.